Clonazepam is an effective treatment for hyperekplexia due to a SLC6A5 (GlyT2) mutation. Movement disorders : official journal of the Movement Disorder Society [Mov Disord] Journal article

Title	Clonazepam is an effective treatment for hyperekplexia due to a SLC6A5 (GlyT2) mutation.
Author(s)	Bakker MJ, Peeters EA, Tijssen MA
Institution	Department of Neurology and Clinical Neurophysiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Source	Mov Disord 2009 Jun 26.
Language	ENG
Pub Type(s)	JOURNAL ARTICLE
PubMed ID	19562758

Advertise on this site.